Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone versus risperidone plus naltrexone in children with autism spectrum disorder
IRCT201108155280N5Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of risperidone and naltrexone in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Sep 2011; status: completed.
02
Drugs
risperidonenaltrexone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201108155280N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108155280N5.